Multi-Ethnic Genome-Wide Study of Bipolar Disorder

双相情感障碍的多种族全基因组研究

基本信息

项目摘要

DESCRIPTION (provided by applicant): Bipolar disorder is a common (1-2% of population), debilitating and potentially life-threatening psychiatric disorder that is characterized by recurrent, cyclic episodes of depression and (hypo)mania. Evidence from prior studies strongly implicates a genetic basis for the etiology of bipolar disorder. However, identification of the genetic factors that determine susceptibility has been elusive. Three recent genome-wide association (GWA) studies of bipolar disorder have produced few robust associations. These findings suggest that the genetic complexity of the disorder may require significantly larger sample sizes and a more comprehensive genetic platform, to detect the large number of associations with modest effects that may underlie the genetic basis of this disorder. This project is a collaboration of investigators at the Kaiser Permanente Division of Research and the University of California, San Francisco Institute for Human Genetics. The overall goal of the proposed study is to discover and characterize common genetic variants that may be associated with the risk of bipolar disorder, by conducting a GWA study of an ethnically diverse sample of 6,000 cases of bipolar disorder and 6,000 controls, ascertained among the members of the Kaiser Permanente Medical Care Plan, Northern California Region (KPNC). Cases and controls will be identified from longitudinal electronic medical records (EMR). To increase phenotypic homogeneity, the sampling frame will be limited to individuals with bipolar I disorder with multiple treatment episodes. Controls will be frequency-matched to cases on gender, current age, self- identified race-ethnicity, zip code, and length of membership in KPNC. Collection of saliva samples for obtaining DNA will be supported by the Kaiser Permanente Research Program on Genes, Environment and Health. Genetic analyses will be done at the UCSF Institute for Human Genetics and Genomics Core Facility. The specific aims for this study are to perform a GWA study of bipolar I disorder in the cases and controls described above using the Affymetrix 6.0 chip platform. We will analyze approximately nine hundred thousand single nucleotide polymorphisms (SNPs) and a similar number of copy number probes to assess potential case-control differences in genotype and haplotype frequencies, as well as copy number variation. Each ethnic subsample will be examined for population stratification, and consistency of results across ethnic groups will be evaluated. Formal significance will be determined by taking into account the large number of variants tested. Related phenotypes, such as the presence of psychotic symptoms or age at onset, will also be evaluated for potential associations with SNPs from the genome-wide scan. Collaborative studies with similar GWA study data will be undertaken to validate significant findings from our own and others' studies. Bipolar disorder is a relatively common psychiatric disorder that often involves impairment of occupational and social functioning and an increased risk of suicide. The causes of bipolar disorder are virtually unknown; however, a genetic basis for the disorder has been strongly implicated in previous studies. Genome-wide association studies in large, well-characterized samples such as the one proposed, can provide information about specific genetic factors that increase the risk of bipolar disorder, potentially leading to increased understanding of the underlying causes of the disorder, and to more reliable diagnoses and new treatments as well.
描述(由申请人提供):双相情感障碍是一种常见的(占人口的1-2%),使人衰弱并可能危及生命的精神疾病,其特征是反复发作,循环发作的抑郁症和(轻度)躁狂。先前研究的证据强烈暗示了双相情感障碍病因的遗传基础。然而,确定易感性的遗传因素一直难以捉摸。最近对双相情感障碍的三个全基因组关联(GWA)研究几乎没有产生强有力的关联。这些发现表明,该疾病的遗传复杂性可能需要更大的样本量和更全面的遗传平台,以检测可能构成该疾病遗传基础的大量关联,这些关联可能具有适度的影响。该项目是Kaiser Permanente研究部和加州大学旧金山人类遗传学研究所的研究人员的合作项目。该研究的总体目标是发现和描述可能与双相情感障碍风险相关的常见遗传变异,通过对6000例双相情感障碍和6000例对照的种族多样化样本进行GWA研究,确定在北加州地区(KPNC)凯撒永久医疗计划的成员中。病例和对照将从纵向电子病历(EMR)中确定。为了增加表型的同质性,采样框架将限于患有多次治疗发作的双相I型障碍的个体。对照将根据性别、当前年龄、自我认定的种族、邮政编码和KPNC会员资格的长短与病例进行频率匹配。收集唾液样本以获得DNA将由Kaiser Permanente基因、环境和健康研究计划提供支持。基因分析将在加州大学旧金山分校人类遗传学和基因组学核心设施研究所进行。本研究的具体目的是使用Affymetrix 6.0芯片平台对上述病例和对照组进行双相I型障碍的GWA研究。我们将分析大约90万个单核苷酸多态性(snp)和相似数量的拷贝数探针,以评估基因型和单倍型频率以及拷贝数变化的潜在病例对照差异。将对每个民族子样本进行人口分层检查,并评估各民族结果的一致性。正式意义将通过考虑测试的大量变体来确定。相关表型,如精神病症状的存在或发病年龄,也将被评估与全基因组扫描的snp的潜在关联。将采用类似的GWA研究数据进行合作研究,以验证我们自己和他人研究的重要发现。双相情感障碍是一种相对常见的精神障碍,通常涉及职业和社会功能的损害以及自杀风险的增加。双相情感障碍的病因实际上是未知的;然而,先前的研究强烈地暗示了这种疾病的遗传基础。在大的、特征明确的样本中进行全基因组关联研究,例如所提出的样本,可以提供有关增加双相情感障碍风险的特定遗传因素的信息,可能导致对该疾病潜在原因的进一步了解,以及更可靠的诊断和新的治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CATHERINE Ann SCHAEFER其他文献

CATHERINE Ann SCHAEFER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CATHERINE Ann SCHAEFER', 18)}}的其他基金

Multi-Ethnic Genome-Wide Study of Bipolar Disorder
双相情感障碍的多种族全基因组研究
  • 批准号:
    7881408
  • 财政年份:
    2008
  • 资助金额:
    $ 76.22万
  • 项目类别:
Multi-Ethnic Genome-Wide Study of Bipolar Disorder
双相情感障碍的多种族全基因组研究
  • 批准号:
    7694985
  • 财政年份:
    2008
  • 资助金额:
    $ 76.22万
  • 项目类别:
Multi-Ethnic Genome-Wide Study of Bipolar Disorder
双相情感障碍的多种族全基因组研究
  • 批准号:
    8090453
  • 财政年份:
    2008
  • 资助金额:
    $ 76.22万
  • 项目类别:
Prenatal Determinants of Schizophrenia, II
精神分裂症的产前决定因素,II
  • 批准号:
    7678383
  • 财政年份:
    2005
  • 资助金额:
    $ 76.22万
  • 项目类别:
Prenatal Determinants of Schizophrenia, II
精神分裂症的产前决定因素,II
  • 批准号:
    7126765
  • 财政年份:
    2005
  • 资助金额:
    $ 76.22万
  • 项目类别:
Prenatal Determinants of Schizophrenia, II
精神分裂症的产前决定因素,II
  • 批准号:
    6928374
  • 财政年份:
    2005
  • 资助金额:
    $ 76.22万
  • 项目类别:
Prenatal Determinants of Schizophrenia, II
精神分裂症的产前决定因素,II
  • 批准号:
    7279107
  • 财政年份:
    2005
  • 资助金额:
    $ 76.22万
  • 项目类别:
Prenatal Determinants of Schizophrenia, II
精神分裂症的产前决定因素,II
  • 批准号:
    7500084
  • 财政年份:
    2005
  • 资助金额:
    $ 76.22万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 76.22万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76.22万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 76.22万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76.22万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 76.22万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76.22万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 76.22万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 76.22万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 76.22万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76.22万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了